Who
Hannah Fry
VP, Controller
Company insider
Files Form 4 as: VP, Controller, Protara Therapeutics.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Jul 2022
- Last trade
- 26 Jan 2026
- Last filed
- 27 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jan 2026filed 27 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $9,7181,457 at $6.67 | filing |
| 26 Jan 2026filed 27 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $9,7181,457 at $6.67 | filing |
| 20 Jan 2026filed 22 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $12K2,132 at $5.60 | filing |
| 20 Jan 2026filed 22 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $12K2,132 at $5.60 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,500 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,500 at $0.00 | filing |
| 24 Jan 2025filed 28 Jan 2025 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 24 Jan 2025filed 28 Jan 2025 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,500 at $0.00 | filing |
| 21 Jan 2025filed 23 Jan 2025 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $10K2,130 at $4.76 | filing |
| 3 Jan 2025filed 7 Jan 2025 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $2,419394 at $6.14 | filing |
| 19 Jan 2024filed 23 Jan 2024 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,000 at $0.00 | filing |
| 19 Jan 2024filed 23 Jan 2024 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 19 Jan 2024filed 23 Jan 2024 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $1,727904 at $1.91 | filing |
| 3 Jan 2024filed 5 Jan 2024 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $703324 at $2.17 | filing |
| 17 Jul 2023filed 18 Jul 2023 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $26K10,075 at $2.56 | filing |
| 19 Jan 2023filed 20 Jan 2023 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,400 at $0.00 | filing |
| 19 Jan 2023filed 20 Jan 2023 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,900 at $0.00 | filing |
| 3 Jan 2023filed 4 Jan 2023 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $1,011361 at $2.80 | filing |
News
Hannah Fry: How OpenAI has caused an existential crisis in mathematicsnewscientist.com · 14 Oct 2026Celebrity Traitors viewers spot HUGE slip up from Hannah Frydailymail.com · 10 Oct 2026Hannah Fry's jumpers from The Celebrity Traitors are almost affordablethetab.com · 9 Oct 2026Celebrity Traitors star Hannah Fry details being diagnosed with cervical cancer, having a radical hysterectomy and going through a divorce all before the age of 40dailymail.com · 9 Oct 2026Celebrity Traitors' new recruit Hannah Fry unveils her 'statistically, perfect approach to catching a traitor' after revealing she brought a spreadsheet into the castledailymail.com · 9 Oct 2026Perfecting nuclear fusion, and other ways to pull Hannah Frythedailymash.co.uk · 6 Oct 2026Hannah Fry announces Come Fry With Me UK tour - ATV Todayatvtoday.co.uk · 21 Sep 2026
7 headlines in the last 90 days name Hannah Fry; no company of theirs resolves to a name we track.
Sectors
No trade we could place in a sector.